Cargando…

Drug-Coated Balloon Angioplasty and Debulking for the Treatment of Femoropopliteal In-Stent Restenosis: A Systematic Review and Meta-Analysis

The purpose of this article was to compare the efficiency and safety of drug-coated balloon angioplasty (DCB) and atherectomy with percutaneous transluminal angioplasty (PTA) in patients with femoropopliteal in-stent restenosis (ISR). Pubmed, Embase, and the Cochrane Central Register of Controlled T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Zhu, Guo, Lianrui, Qi, Lixing, Cui, Shijun, Gao, Xixiang, Li, Yang, Guo, Jianming, Gu, Yongquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303732/ https://www.ncbi.nlm.nih.gov/pubmed/32596293 http://dx.doi.org/10.1155/2020/3076346

Ejemplares similares

Debulking plus drug-coated balloon angioplasty versus drug-coated balloon angioplasty alone for femoropopliteal Tosaka III in-stent restenosis lesions
por: Li, Liqiang, et al.
Publicado: (2022)

Drug-coated balloon angioplasty versus balloon angioplasty for treating patients with in-stent restenosis in the femoropopliteal artery: A meta-analysis
por: Cao, Shaobo, et al.
Publicado: (2021)

Drug-Coated Balloon for the Treatment of Femoropopliteal Tosaka Class III In-stent Restenosis Lesions
por: Zhang, Bihui, et al.
Publicado: (2021)

Outcomes of covered stents versus bare-metal stents for subclavian artery occlusive disease
por: Wei, Libing, et al.
Publicado: (2023)

Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
por: Horie, Kazunori, et al.
Publicado: (2021)

Feasibility and Safety of Paclitaxel-Coated Balloon Angioplasty for the Treatment of Intracranial Symptomatic In-Stent Restenosis
por: Xu, Haowen, et al.
Publicado: (2020)

Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012)

Treatment of Femoropopliteal Artery In-stent Restenosis
por: Kim, Wonho, et al.
Publicado: (2018)

Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
por: Shirai, Shigemitsu, et al.
Publicado: (2022)

Efficacy and Prediction Model Construction of Drug-Coated Balloon Combined with Cutting Balloon Angioplasty in the Treatment of Drug-Eluting Stent In-Stent Restenosis
por: Wu, Haokun, et al.
Publicado: (2022)

Comparison of Balloon Angioplasty and Stent Implantation for Femoropopliteal Disease According to Patient and Lesion Subgroup
por: Kobayashi, Norihiro, et al.
Publicado: (2019)

Five-Year Outcomes of Post-Drug-Coated Balloon Angioplasty Dissection in Complex Femoropopliteal Artery Disease
por: Ren, Hao, et al.
Publicado: (2021)

Intravascular Lithotripsy and Drug-Coated Balloon Angioplasty for Severely Calcified Femoropopliteal Arterial Disease
por: Stavroulakis, Konstantinos, et al.
Publicado: (2022)

Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis
por: Xue, Weihao, et al.
Publicado: (2022)

Differential efficacy between stenting and plain balloon angioplasty for femoropopliteal disease with or without total occlusion
por: Chae, In-Ho, et al.
Publicado: (2020)

Unusual Response of Subclavian In-Stent Restenosis to Balloon Angioplasty in a Patient with HIV
por: Rana, Mohammad Atif, et al.
Publicado: (2015)

Excimer laser atherectomy combined with drug-coated balloon angioplasty for the treatment of chronic obstructive femoropopliteal arterial disease
por: Liu, Hui, et al.
Publicado: (2020)

The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty
por: Oh, Pyung Chun, et al.
Publicado: (2016)

What Is the Future of Drug-Coated Balloons for In-Stent Restenosis?
por: Chen, Yun-Dai, et al.
Publicado: (2022)

Drug-coated balloons for the treatment of stent edge restenosis
por: Nagasaka, Takashi, et al.
Publicado: (2023)

Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort
por: Torsello, Giovanni, et al.
Publicado: (2020)

Neutrophil-to-Lymphocyte Ratio Predicts Restenosis After Drug-Coated Balloon Therapy for Femoropopliteal Artery Lesions: A Retrospective Study
por: Wang, Zhihong, et al.
Publicado: (2022)

Prolonged high-pressure balloon angioplasty of femoropopliteal lesions: Impact on stent implantation rate and mid-term outcome
por: Rigatelli, Gianluca, et al.
Publicado: (2014)

Clinical implication of quantitative flow ratio to predict clinical events after drug‐coated balloon angioplasty in patients with in‐stent restenosis
por: Tang, Jiani, et al.
Publicado: (2021)

Emerging Stent and Balloon Technologies in the Femoropopliteal Arteries
por: Pastromas, Georgios, et al.
Publicado: (2014)

Drug-coated balloon in superficial femoral artery in-stent restenosis
por: Gerardi, Donato, et al.
Publicado: (2018)

Impact of plaque and luminal morphology in balloon angioplasty of the femoropopliteal artery: an intravascular ultrasound analysis
por: Zou, Yuchi, et al.
Publicado: (2023)

Cost-effectiveness analysis of orbital atherectomy plus balloon angioplasty vs balloon angioplasty alone in subjects with calcified femoropopliteal lesions
por: Weinstock, Barry, et al.
Publicado: (2014)

Serial optical coherence tomography and angioscopic assessments of 10-year in-stent restenosis of Cypher sirolimus-eluting stent treated with drug-coated balloon angioplasty
por: Suzuki, Satoshi, et al.
Publicado: (2019)

Combination of Rotational Atherothrombectomy and Paclitaxel-Coated Angioplasty for Femoropopliteal Occlusion
por: Scheer, F, et al.
Publicado: (2015)

Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: An observational follow-up study of first-time versus repeated restenosis
por: Abdelmegid, Mohamed Aboel-Kassem F., et al.
Publicado: (2017)

Increased Plasma Cathepsin s at the Time of Percutaneous Transluminal Angioplasty is Associated with 6-months’ Restenosis of the Femoropopliteal Artery
por: Mijovski, Mojca Bozic, et al.
Publicado: (2018)

Endovascular Treatment and Outcomes for Femoropopliteal In-Stent Restenosis: Insights from the XLPAD Registry
por: Vu, Michael H., et al.
Publicado: (2022)

Experimental Liver Cirrhosis Inhibits Restenosis after Balloon Angioplasty
por: Mechelinck, Mare, et al.
Publicado: (2023)

Autologous bone marrow-derived mononuclear cell therapy in Chinese patients with critical limb ischemia due to thromboangiitis obliterans: 10-year results
por: Guo, Jianming, et al.
Publicado: (2018)

Design of the FP-RESTORE study: a protocol for prospective, observational study of real-world treatments with endovascular therapy in patients with femoropopliteal artery Tosaka III in-stent restenosis
por: Li, Xu, et al.
Publicado: (2022)

Balloon-Assisted Angioplasty for the Treatment of In-Stent Restenosis After Vertebral Artery Ostium Stenting: Experiences From One Single Center
por: Cai, Xueli, et al.
Publicado: (2021)

Enabling Angioplasty‐Ready “Smart” Stents to Detect In‐Stent Restenosis and Occlusion
por: Chen, Xing, et al.
Publicado: (2018)

Novel Fabrication of MicroRNA Nanoparticle-Coated Coronary Stent for Prevention of Post-Angioplasty Restenosis
por: Che, Hui-Lian, et al.
Publicado: (2016)

Long‐term outcomes after paclitaxel‐coated balloon angioplasty of femoropopliteal arteries in Asian patients of the IN.PACT Global Study
por: Ko, Young‐Guk, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ufuiodat59kkpov6mglgcgn4sf